Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

1.

Experience with combination of cetuximab plus intensity-modulated radiotherapy with or without chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

Niu X, Hu C, Kong L.

J Cancer Res Clin Oncol. 2013 Jun;139(6):1063-71. doi: 10.1007/s00432-013-1419-z. Epub 2013 Mar 24.

PMID:
23525586
[PubMed - indexed for MEDLINE]
2.

Experience with combination of cisplatin plus gemcitabine chemotherapy and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.

He X, Ou D, Ying H, Zhu G, Hu C, Liu T.

Eur Arch Otorhinolaryngol. 2012 Mar;269(3):1027-33. doi: 10.1007/s00405-011-1669-9. Epub 2011 Jun 26. Erratum in: Eur Arch Otorhinolaryngol. 2012 Mar;269(3):1035. Xiayun, He [corrected to He, Xiayun]..

PMID:
21706324
[PubMed - indexed for MEDLINE]
3.

Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Han L, Lin SJ, Pan JJ, Chen CB, Zhang Y, Zhang XC, Liao XY, Chen QS.

Chin J Cancer. 2010 Feb;29(2):145-50.

PMID:
20109341
[PubMed - indexed for MEDLINE]
Free Article
4.

Neoadjuvant chemotherapy followed by concurrent chemoradiation for locally advanced nasopharyngeal carcinoma.

Kong L, Zhang YW, Hu CS, Guo Y.

Chin J Cancer. 2010 May;29(5):551-5.

PMID:
20426907
[PubMed - indexed for MEDLINE]
Free Article
5.

Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases.

Lin S, Lu JJ, Han L, Chen Q, Pan J.

BMC Cancer. 2010 Feb 10;10:39. doi: 10.1186/1471-2407-10-39.

PMID:
20146823
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma.

Ma BB, Kam MK, Leung SF, Hui EP, King AD, Chan SL, Mo F, Loong H, Yu BK, Ahuja A, Chan AT.

Ann Oncol. 2012 May;23(5):1287-92. doi: 10.1093/annonc/mdr401. Epub 2011 Sep 23.

PMID:
21948811
[PubMed - indexed for MEDLINE]
Free Article
7.

Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.

Lee N, Harris J, Garden AS, Straube W, Glisson B, Xia P, Bosch W, Morrison WH, Quivey J, Thorstad W, Jones C, Ang KK.

J Clin Oncol. 2009 Aug 1;27(22):3684-90. doi: 10.1200/JCO.2008.19.9109. Epub 2009 Jun 29.

PMID:
19564532
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.

Kim K, Wu HG, Kim HJ, Sung MW, Kim KH, Lee SH, Heo DS, Kim HJ, Park CI.

Head Neck. 2009 Sep;31(9):1121-8. doi: 10.1002/hed.21076.

PMID:
19340863
[PubMed - indexed for MEDLINE]
9.

Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma.

Du C, Ying H, Zhou J, Hu C, Zhang Y.

Int J Clin Oncol. 2013 Jun;18(3):464-71. doi: 10.1007/s10147-012-0403-y. Epub 2012 Apr 13.

PMID:
22527846
[PubMed - indexed for MEDLINE]
10.

Phase II trial of neoadjuvant docetaxel and cisplatin followed by intensity-modulated radiotherapy with concurrent cisplatin in locally advanced nasopharyngeal carcinoma.

Zhong YH, Dai J, Wang XY, Xie CH, Chen G, Zeng L, Zhou YF.

Cancer Chemother Pharmacol. 2013 Jun;71(6):1577-83. doi: 10.1007/s00280-013-2157-2. Epub 2013 Apr 3.

PMID:
23549883
[PubMed - indexed for MEDLINE]
11.

A comparative study of locoregionally advanced nasopharyngeal carcinoma treated with intensity modulated irradiation and platinum-based chemotherapy.

Xu JH, Guo WJ, Bian XH, Wu JF, Jiang XS, Guo YS, He X.

Cancer Radiother. 2013 Jul-Aug;17(4):297-303. doi: 10.1016/j.canrad.2013.03.006. Epub 2013 Jul 9.

PMID:
23849438
[PubMed - indexed for MEDLINE]
12.

Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.

Tao CJ, Liu X, Tang LL, Mao YP, Chen L, Li WF, Yu XL, Liu LZ, Zhang R, Lin AH, Ma J, Sun Y.

Chin J Cancer. 2013 Oct;32(10):525-32. doi: 10.5732/cjc.013.10124. Epub 2013 Sep 10.

PMID:
24016394
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysis.

Saleh-Ebrahimi L, Zwicker F, Muenter MW, Bischof M, Lindel K, Debus J, Huber PE, Roeder F.

Radiat Oncol. 2013 Jan 24;8:20. doi: 10.1186/1748-717X-8-20.

PMID:
23347410
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Intensity-modulated radiation therapy without concurrent chemotherapy for stage IIb nasopharyngeal cancer.

Tham IW, Lin S, Pan J, Han L, Lu JJ, Wee J.

Am J Clin Oncol. 2010 Jun;33(3):294-9. doi: 10.1097/COC.0b013e3181d2edab.

PMID:
20395788
[PubMed - indexed for MEDLINE]
15.

Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.

Kam MK, Teo PM, Chau RM, Cheung KY, Choi PH, Kwan WH, Leung SF, Zee B, Chan AT.

Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1440-50.

PMID:
15590175
[PubMed - indexed for MEDLINE]
16.

Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.

Sultanem K, Shu HK, Xia P, Akazawa C, Quivey JM, Verhey LJ, Fu KK.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):711-22.

PMID:
11020568
[PubMed - indexed for MEDLINE]
17.

Long-term treatment outcome of recurrent nasopharyngeal carcinoma treated with salvage intensity modulated radiotherapy.

Hua YJ, Han F, Lu LX, Mai HQ, Guo X, Hong MH, Lu TX, Zhao C.

Eur J Cancer. 2012 Dec;48(18):3422-8. doi: 10.1016/j.ejca.2012.06.016. Epub 2012 Jul 25.

PMID:
22835782
[PubMed - indexed for MEDLINE]
18.

Intensity-modulated radiotherapy with simultaneous modulated accelerated boost technique and chemotherapy in patients with nasopharyngeal carcinoma.

Fareed MM, AlAmro AS, Bayoumi Y, Tunio MA, Ismail AS, Akasha R, Mubasher M, Al Asiri M.

BMC Cancer. 2013 Jul 1;13:318. doi: 10.1186/1471-2407-13-318.

PMID:
23815822
[PubMed - indexed for MEDLINE]
Free PMC Article
19.
20.

Definitive intensity-modulated radiation therapy for nasopharyngeal carcinoma: long-term outcome of a multicenter prospective study.

Wang R, Wu F, Lu H, Wei B, Feng G, Li G, Liu M, Yan H, Zhu J, Zhang Y, Hu K.

J Cancer Res Clin Oncol. 2013 Jan;139(1):139-45. doi: 10.1007/s00432-012-1313-0. Epub 2012 Sep 18.

PMID:
22986812
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk